Document is current
Any future updates will be listed below
-
Authors
Watzlowik, Maria Theresia
Silberhorn, Elisabeth
Das, Sujaan
Singhal, Ritwik
Venugopal, Kannan https://orcid.org/0000-0002-1620-5524
Holzinger, Simon https://orcid.org/0009-0003-0651-4563
Stokes, Barbara
Schadt, Ella https://orcid.org/0009-0000-4572-3489
Sollelis, Lauriane
Bonnell, Victoria A.
Gow, Matthew
Klingl, Andreas https://orcid.org/0000-0001-8414-8317
Marti, Matthias https://orcid.org/0000-0003-1040-9566
Llinás, Manuel
Meissner, Markus https://orcid.org/0000-0002-5341-5969
Längst, Gernot https://orcid.org/0000-0002-8232-1179
- License Information
-
More Information
Article History
Received: 27 June 2023
Accepted: 3 January 2025
First Online: 19 February 2025
Competing interests
: University of Regensburg has registered a patent for NH125 as CRE inhibitor with G.L., M.T.W. and 2bind listed as inventors (application number EP 23 219 442.3). The other authors declare no competing interests.
